2,4,5-Trimethoxyphenethylamine
| Clinical data | |
|---|---|
| Other names | 2,4,5-TMPEA; TMPEA-2; TMPEA; 4-Methoxy-2,5-dimethoxyphenethylamine; 2,5-Dimethoxy-4-methoxyphenethylamine; 2C-O; 2C-OMe; 2C-MeO; 2C-TMA-2; 25O |
| Routes of administration | Oral |
| Drug class | Serotonin receptor agonist; Serotonin 5-HT2 receptor agonist |
| ATC code |
|
| Legal status | |
| Legal status |
|
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| Chemical and physical data | |
| Formula | C11H17NO3 |
| Molar mass | 211.261 g·mol−1 |
| 3D model (JSmol) | |
| Melting point | 187 to 188 °C (369 to 370 °F) |
| |
| |
| (verify) | |
2C-O, also known as 2,4,5-trimethoxyphenethylamine (2,4,5-TMPEA) or TMPEA-2, is a chemical compound of the phenethylamine and 2C families. It is a positional isomer of mescaline (3,4,5-trimethoxyphenethylamine) and is the α-desmethyl analogue of 2,4,5-trimethoxyamphetamine (TMA-2). The drug is the parent compound of the 2C-O series of drugs. 2C-O appears to be inactive in terms of psychoactive effects in humans. It was first described by Jansen in 1931.